LCI may have a role in the routine clinical care of both adult and pediatric CF patients as a good tool to assess response to IV antibiotic end-therapy in the same way as FEV1.
Keyphrases
- cystic fibrosis
- end stage renal disease
- ejection fraction
- pseudomonas aeruginosa
- newly diagnosed
- chronic obstructive pulmonary disease
- chronic kidney disease
- palliative care
- pulmonary hypertension
- intensive care unit
- stem cells
- clinical practice
- acute respiratory distress syndrome
- bone marrow
- pain management
- mechanical ventilation
- affordable care act